Opt-41

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameOpt-41
Drug Alias NameCMV/HSV therapy (OPTIS)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHerpes SimplexCytomegalovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKiora Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKiora Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHerpes SimplexCytomegalovirus Infections

Other Information

ATC CodeN/A
Related LinksN/A